ChemicalBook >> journal list >> Pharmaceuticals >>article
Pharmaceuticals

Pharmaceuticals

IF: 4.3
Download PDF

Potential Ameliorative Effect of Aged Liubao Tea Aqueous Extract on D-Galactose-Induced Pathological Damage in an Alzheimer’s Disease Zebrafish Model

Published:24 August 2026 DOI: 10.3390/ph19091336
Shini Zhang, Xiao-Li Luo, Hangxing Yang, Ganghua Huang, Jing Leng, Tao Yang

Abstract

Background: Alzheimer’s disease (AD) is a prevalent neurodegenerative disorder for which effective treatments remain limited. Liubao tea, a distinctive post-fermented dark tea, develops unique aged and areca nut aromas through prolonged storage. However, comprehensive studies on its anti-Alzheimer’s disease effects are lacking. This study aimed to identify the bioactive constituents of Liubao tea with varying storage durations and aroma profiles, and to further evaluate its neuroprotective potential against Alzheimer’s disease. Methods: Chromatography and spectrophotometry were employed to quantitatively determine the primary bioactive components in various Liubao tea samples. A D-galactose-induced Alzheimer’s disease zebrafish (Danio rerio) model was established to evaluate the neuroprotective effects of the aqueous extract of Liubao tea. Results: The contents of theabrownins, theaflavins, tea pigments, and catechins showed potential associations with the anti-AD capacity of Liubao tea. Variations in these bioactive components appeared to correlate with the neuroprotective activity. Conclusions: This study elucidates the anti-AD potential of aged Liubao tea and associates its characteristic constituents with neuroprotective effects. The findings provide essential theoretical support for developing Liubao tea as a promising natural product candidate worthy of further anti-AD research.

Substances (1)

Materials
Procduct Name CAS Molecular Formula Supplier Price
Gallic acid 149-91-7 C7H6O5 975 suppliers $5.00-$1754.50

Similar articles

IF:2

L-histidine and L-carnosine exert anti-brain aging effects in D-galactose-induced aged neuronal cells.

Nutrition Research and Practice Yerin Kim, Yuri Kim,etc Published: 1 June 2020
IF:4.4

Palmitoylethanolamide (PEA) as a Potential Therapeutic Agent in Alzheimer’s Disease

Frontiers in Pharmacology S. Beggiato, M. C. Tomasini,etc Published: 24 July 2019
IF:3.7

A Synopsis of Multitarget Potential Therapeutic Effects of Huperzine A in Diverse Pathologies–Emphasis on Alzheimer’s Disease Pathogenesis

Neurochemical Research Mayuri Shukla, Prapimpun Wongchitrat,etc Published: 5 February 2022